Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Preparing word cloud

×

Suggested Search Criteria

Enter extra filters to help narrow your search

Search

Type in a keyword to search

Filter by records added date
See new records

Options


Current Facets and Filters

  • References:pmid:25877200 (facet)

Facets


Recent searches

Snippet view Table view
Click the to add this resource to an Authentication Report or Collection

1,167 Results - per page

Show More Columns | Download Top 1000 Results

Name Proper Citation Organism Disease Comments Defining Citation Category Sex Synonyms Vendor Catalog Number Cross References Hierarchy Originate from Same Individual ID Record Last Update Mentions Count
MHH-ES-1
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_1411 Homo sapiens (Human) Ewing sarcoma Population: Caucasian., Part of: Ewing Sarcoma Cell Line Atlas (ESCLA)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:20164919
PMID:22142829
PMID:22460905
PMID:25223734
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
PMID:36476851
Cancer cell line Male MHH-ES1, MHHES1 CLO:CLO_0007718,
EFO:EFO_0006650,
CLDB:cl3478,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:185,
BioSample:SAMN03471911,
BioSample:SAMN03473362,
BioSample:SAMN10988548,
cancercelllines:CVCL_1411,
Cell_Model_Passport:SIDM00386,
ChEMBL-Cells:CHEMBL3308762,
ChEMBL-Targets:CHEMBL1075505,
CLS:300136,
Cosmic:908134,
Cosmic:1718436,
Cosmic:2250463,
Cosmic-CLP:908134,
DepMap:ACH-000391,
DSMZ:ACC-167,
DSMZCellDive:ACC-167,
EGA:EGAS00001000610,
GDSC:908134,
GEO:GSM887318,
GEO:GSM888394,
GEO:GSM1670106,
GEO:GSM5359670,
GEO:GSM5359671,
GEO:GSM5359672,
GEO:GSM5359673,
GEO:GSM5359674,
GEO:GSM5359675,
GEO:GSM5362922,
GEO:GSM5362923,
GEO:GSM5362924,
GEO:GSM5362925,
GEO:GSM5362926,
GEO:GSM5362927,
GEO:GSM5363976,
GEO:GSM5363977,
GEO:GSM5363978,
GEO:GSM5363979,
GEO:GSM5363980,
IARC_TP53:21501,
LiGeA:CCLE_341,
LINCS_LDP:LCL-1454,
PharmacoDB:MHHES1_928_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1411,
PubChem_Cell_line:CVCL_1411,
Wikidata:Q54905539
CVCL_1411 2026-08-15 04:46:27 7
MIA PaCa-2
 
Resource Report
Resource Website
1000+ mentions
RRID:CVCL_0428 Homo sapiens (Human) Pancreatic undifferentiated carcinoma Caution: Additional TP53 mutation in c.818G>A indicated incorrectly in PubMed=1630814., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:832918
PMID:1630814
PMID:1764370
PMID:7809022
PMID:7961102
PMID:8026879
PMID:8194712
PMID:9290701
PMID:10027410
PMID:11115575
PMID:11169957
PMID:11169959
PMID:11787853
PMID:12068308
PMID:12692724
PMID:14695172
PMID:15770730
PMID:16912165
PMID:17254797
PMID:18298655
PMID:18380791
PMID:18575732
PMID:19077451
PMID:19188929
PMID:19904223
PMID:20037478
PMID:20164919
PMID:20215515
PMID:20418756
PMID:21607521
PMID:22460905
PMID:22585861
PMID:23386380
PMID:25167228
PMID:25485619
PMID:25485960
PMID:25877200
PMID:25984343
PMID:26216984
PMID:26884312
PMID:27067801
PMID:27259358
PMID:27397505
PMID:28196595
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31037374
PMID:31068700
PMID:31978347
PMID:32782605
PMID:34207840
PMID:35839778
Cancer cell line Male MIA-PaCa-2, MIA-PACA-2, MIA-Pa-Ca-2, MIA Paca2, MIA PaCa2, MiaPaCa-2, MIAPACA-2, MiaPaca.2, MiaPaCa2, Miapaca2, MIAPaCa2, MIAPACA2, Mia PACA 2, MIAPaCa-2, PaCa2, MiaPaCa, MIAMI Pancreatic Carcinoma-2 BTO:BTO_0002137,
CLO:CLO_0007726,
CLO:CLO_0050101,
EFO:EFO_0002236,
MCCL:MCC:0000325,
CLDB:cl3480,
CLDB:cl3481,
CLDB:cl3482,
AddexBio:C0018002/59,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3263,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1420,
ATCC:CRM-CRL-1420,
BCRC:60139,
BCRJ:0174,
BioGRID_ORCS_Cell_line:544,
BioSample:SAMN01821579,
BioSample:SAMN01821700,
BioSample:SAMN03472131,
BioSample:SAMN10988205,
cancercelllines:CVCL_0428,
CCRID:3101HUMSCSP568,
CCRID:4201HUM-CCTCC00255,
CCTCC:GDC0255,
Cell_Model_Passport:SIDM00505,
CGH-DB:321-1,
CGH-DB:9374-4,
ChEMBL-Cells:CHEMBL3308500,
ChEMBL-Targets:CHEMBL614725,
CLS:300438,
Cosmic:707249,
Cosmic:710861,
Cosmic:719677,
Cosmic:724644,
Cosmic:724870,
Cosmic:730532,
Cosmic:808172,
Cosmic:868243,
Cosmic:872996,
Cosmic:913313,
Cosmic:918056,
Cosmic:922249,
Cosmic:923170,
Cosmic:932520,
Cosmic:947399,
Cosmic:948373,
Cosmic:948731,
Cosmic:949234,
Cosmic:968107,
Cosmic:1006368,
Cosmic:1066202,
Cosmic:1108337,
Cosmic:1198208,
Cosmic:1299302,
Cosmic:1320461,
Cosmic:1366278,
Cosmic:1477431,
Cosmic:1534318,
Cosmic:1571779,
Cosmic:1609545,
Cosmic:1644314,
Cosmic:1995507,
Cosmic:2434084,
Cosmic:2664042,
Cosmic:2668287,
Cosmic:2755950,
Cosmic-CLP:724870,
DepMap:ACH-000601,
DSMZ:ACC-733,
DSMZCellDive:ACC-733,
ECACC:85062806,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10488-107B2,
FCS-free:216-2-440-1-3-6,
GDSC:724870,
GEO:GSM206526,
GEO:GSM244425,
GEO:GSM621895,
GEO:GSM784703,
GEO:GSM887320,
GEO:GSM888396,
GEO:GSM1024404,
GEO:GSM1374677,
GEO:GSM1374678,
GEO:GSM1374679,
GEO:GSM1435696,
GEO:GSM1435697,
GEO:GSM1435698,
GEO:GSM1588612,
GEO:GSM1588624,
GEO:GSM1670109,
GEO:GSM5481591,
GEO:GSM5481592,
GEO:GSM5481593,
GEO:GSM5481594,
IARC_TP53:316,
IGRhCellID:MIAPaCa,
IZSLER:BS TCL 42,
JCRB:JCRB0070,
KCLB:21420,
LiGeA:CCLE_231,
LINCS_LDP:LCL-1738,
Lonza:751,
MetaboLights:MTBLS812,
NCBI_Iran:C459,
PharmacoDB:MIAPaCa2_931_2019,
PRIDE:PXD001260,
PRIDE:PXD003198,
PRIDE:PXD030304,
Progenetix:CVCL_0428,
PubChem_Cell_line:CVCL_0428,
RCB:RCB2094,
SKY/M-FISH/CGH:1996,
TKG:TKG 0227,
Wikidata:Q54905679
CVCL_0428 2026-08-15 04:46:23 1066
LCLC-97TM1
 
Resource Report
Resource Website
RRID:CVCL_1376 Homo sapiens (Human) Lung large cell carcinoma Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:2840315
PMID:20164919
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26361996
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
Cancer cell line Male LCLC97TM1, Large Cell Lung Cancer-97TM1 CLO:CLO_0007283,
EFO:EFO_0006635,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:928,
BioSample:SAMN03473042,
BioSample:SAMN03473572,
BioSample:SAMN10988572,
cancercelllines:CVCL_1376,
Cell_Model_Passport:SIDM00344,
ChEMBL-Cells:CHEMBL3308112,
ChEMBL-Targets:CHEMBL1075489,
CLS:300409,
Cosmic:946361,
Cosmic:1146948,
Cosmic:1995482,
Cosmic-CLP:946361,
DepMap:ACH-000596,
DSMZ:ACC-388,
DSMZCellDive:ACC-388,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:946361,
GEO:GSM434288,
GEO:GSM784234,
GEO:GSM887265,
GEO:GSM888340,
GEO:GSM1670046,
IARC_TP53:27176,
IGRhCellID:LCLC97TM1GEO,
LiGeA:CCLE_643,
LINCS_LDP:LCL-1782,
PharmacoDB:LCLC97TM1_834_2019,
PRIDE:PXD002556,
PRIDE:PXD030304,
Progenetix:CVCL_1376,
PubChem_Cell_line:CVCL_1376,
Wikidata:Q54902346
CVCL_1376 2026-08-15 04:44:56 0
Li-7
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_3840 Homo sapiens (Human) Adult hepatocellular carcinoma Population: Japanese., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:85491
PMID:2542205
PMID:12029633
PMID:15767549
PMID:22460905
PMID:23887712
PMID:25877200
PMID:30784169
PMID:30894373
PMID:31063779
PMID:31068700
PMID:31378681
PMID:37610679
Cancer cell line Male LI7, Li7, C-Li-7 CLO:CLO_0050854,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:571,
BioSample:SAMN03470992,
BioSample:SAMN10987749,
cancercelllines:CVCL_3840,
CCRID:1101HUM-PUMC000678,
CCRID:3101HUMSCSP5062,
CCRID:3101HUMTCHu183,
Cell_Model_Passport:SIDM01472,
CGH-DB:9074-4,
CLS:305102,
Cosmic:721062,
Cosmic:2023862,
Cosmic:2162529,
Cosmic:2771607,
DepMap:ACH-000471,
FANTOM5_SSTAR:10484-107A7,
GEO:GSM565882,
GEO:GSM887266,
GEO:GSM888341,
GEO:GSM2551577,
IARC_TP53:30113,
LiGeA:CCLE_219,
LIMORE:Li7,
PharmacoDB:Li7_835_2019,
PRIDE:PXD002486,
Progenetix:CVCL_3840,
RCB:RCB1941,
TKG:TKG 0368,
Wikidata:Q54902491
CVCL_3840 2026-08-15 04:45:00 9
LNCaP
 
Resource Report
Resource Website
1000+ mentions
RRID:CVCL_0395 Homo sapiens (Human) Prostate carcinoma Population: Caucasian., Part of: ENCODE project common cell types; tier 3., Group: Space-flown cell line (cellonaut). PMID:2734981
PMID:3335022
PMID:3518877
PMID:6831420
PMID:8687134
PMID:9018337
PMID:9090379
PMID:9460501
PMID:10702678
PMID:10972993
PMID:11135431
PMID:11172901
PMID:11304728
PMID:11414198
PMID:11416159
PMID:12606952
PMID:12725112
PMID:14518029
PMID:15162376
PMID:15486987
PMID:22213130
PMID:22278370
PMID:23671654
PMID:24587179
PMID:24618588
PMID:25485619
PMID:25877200
PMID:26256267
PMID:26589293
PMID:26972028
PMID:27036029
PMID:27141528
PMID:29194687
PMID:29233929
PMID:29660373
PMID:29739788
PMID:30787054
PMID:35502546
PMID:38892296
Cancer cell line Male LNCAP, LNCap, Ln-Cap, LNCaP-RPCI, Lymph Node Carcinoma of the prostate BTO:BTO_0001321,
CLO:CLO_0007365,
CLO:CLO_0037116,
EFO:EFO_0002071,
MCCL:MCC:0000290,
CLDB:cl3243,
ArrayExpress:E-MTAB-2706,
BioGRID_ORCS_Cell_line:182,
BioSample:SAMN03472386,
cancercelllines:CVCL_0395,
CCRID:1101HUM-PUMC000040,
CCTCC:GDC0283,
CCTCC:GDC0284,
ChEMBL-Cells:CHEMBL3307965,
ChEMBL-Targets:CHEMBL612518,
CLS:300265,
Cosmic:704848,
Cosmic:721368,
Cosmic:721555,
Cosmic:755298,
Cosmic:759895,
Cosmic:801348,
Cosmic:850413,
Cosmic:850745,
Cosmic:850821,
Cosmic:869155,
Cosmic:918500,
Cosmic:920967,
Cosmic:921047,
Cosmic:922553,
Cosmic:923955,
Cosmic:943176,
Cosmic:948076,
Cosmic:949248,
Cosmic:1028648,
Cosmic:1028701,
Cosmic:1066237,
Cosmic:1070886,
Cosmic:1071481,
Cosmic:1071906,
Cosmic:1075275,
Cosmic:1172626,
Cosmic:1176618,
Cosmic:1330909,
Cosmic:1556120,
Cosmic:1689708,
Cosmic:1995486,
Cosmic:2537792,
Cosmic:2580128,
Cosmic:2585151,
Cosmic:2585228,
Cosmic:2621168,
Cosmic:2651770,
Cosmic:2669169,
Cosmic:2816221,
DSMZ:ACC-256,
DSMZCellDive:ACC-256,
EGA:EGAS00001000610,
GEO:GSE99795,
GEO:GSM91927,
GEO:GSM142457,
GEO:GSM142458,
GEO:GSM383948,
GEO:GSM383953,
GEO:GSM482669,
GEO:GSM525800,
GEO:GSM784790,
GEO:GSM816634,
GEO:GSM816637,
GEO:GSM844579,
GEO:GSM945240,
GEO:GSM945282,
GEO:GSM1022672,
GEO:GSM1029460,
GEO:GSM1029461,
GEO:GSM1029462,
GEO:GSM1029463,
GEO:GSM1029464,
GEO:GSM1029465,
GEO:GSM1029466,
GEO:GSM1029467,
GEO:GSM1374622,
GEO:GSM1374626,
GEO:GSM2069518,
GEO:GSM2069519,
GEO:GSM2069520,
GEO:GSM2069521,
GEO:GSM2069522,
GEO:GSM2069523,
GEO:GSM2069524,
GEO:GSM2069525,
GEO:GSM2650017,
GEO:GSM2650018,
GEO:GSM2650019,
GEO:GSM2650020,
GEO:GSM2650021,
GEO:GSM2650022,
GEO:GSM3145602,
GEO:GSM3145720,
IARC_TP53:21076,
LINCS_LDP:LCL-1298,
Lonza:109,
PharmacoDB:LNCAP_850_2019,
PRIDE:PXD000953,
PRIDE:PXD000985,
PRIDE:PXD002107,
PRIDE:PXD002395,
PRIDE:PXD003105,
PRIDE:PXD003262,
PRIDE:PXD006561,
PRIDE:PXD032264,
Progenetix:CVCL_0395,
PubChem_Cell_line:CVCL_0395,
TOKU-E:3599,
Wikidata:Q6459234
CVCL_0395 2026-08-15 04:45:09 3185
LN-229
 
Resource Report
Resource Website
500+ mentions
RRID:CVCL_0393 Homo sapiens (Human) Glioblastoma Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:7693337
PMID:8509230
PMID:9842975
PMID:10416987
PMID:14614447
PMID:14655754
PMID:16697959
PMID:17595512
PMID:19365568
PMID:20504876
PMID:21406405
PMID:22460905
PMID:22570425
PMID:25485619
PMID:25772239
PMID:25877200
PMID:25894527
PMID:25984343
PMID:26496030
PMID:26589293
PMID:27397505
PMID:27412690
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:35839778
Cancer cell line Female LN 229, LN229, LNT-229 BTO:BTO_0002004,
CLO:CLO_0007363,
EFO:EFO_0006637,
MCCL:MCC:0000288,
AddexBio:C0005017/4993,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2611,
BioGRID_ORCS_Cell_line:929,
BioSample:SAMN03471191,
BioSample:SAMN03471692,
BioSample:SAMN10987619,
cancercelllines:CVCL_0393,
Cell_Model_Passport:SIDM00684,
ChEMBL-Cells:CHEMBL4295402,
ChEMBL-Targets:CHEMBL4296459,
CLS:305043,
Cosmic:849861,
Cosmic:1746958,
Cosmic:1995485,
Cosmic:2302323,
Cosmic:2367492,
Cosmic:2491102,
Cosmic:2516025,
Cosmic:2580915,
Cosmic-CLP:1240169,
DepMap:ACH-000595,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1240169,
GEO:GSM101615,
GEO:GSM101616,
GEO:GSM326200,
GEO:GSM397665,
GEO:GSM397666,
GEO:GSM481416,
GEO:GSM887270,
GEO:GSM888345,
GEO:GSM1374621,
GEO:GSM1670049,
GEO:GSM2113428,
GEO:GSM2113429,
GEO:GSM2113430,
GEO:GSM2113431,
IARC_TP53:30212,
LiGeA:CCLE_871,
LINCS_LDP:LCL-1354,
Lonza:1322,
PharmacoDB:LN229_841_2019,
PRIDE:PXD000589,
PRIDE:PXD003790,
PRIDE:PXD030304,
Progenetix:CVCL_0393,
PubChem_Cell_line:CVCL_0393,
Ubigene:YC-A021,
Wikidata:Q54902771
CVCL_0393 2026-08-15 04:45:08 854
LN-18
 
Resource Report
Resource Website
10+ mentions
RRID:CVCL_0392 Homo sapiens (Human) Glioblastoma Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:7211194
PMID:7693337
PMID:7732013
PMID:8509230
PMID:9842975
PMID:10416987
PMID:14614447
PMID:14655754
PMID:17595512
PMID:21406405
PMID:22460905
PMID:22570425
PMID:25485619
PMID:25877200
PMID:25894527
PMID:26496030
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
Cancer cell line Male LN 18, LN18, LN018 BTO:BTO_0002005,
CLO:CLO_0007362,
EFO:EFO_0006636,
MCCL:MCC:0000287,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2610,
BCRJ:0420,
BioGRID_ORCS_Cell_line:410,
BioSample:SAMN03471122,
BioSample:SAMN10988197,
cancercelllines:CVCL_0392,
Cell_Model_Passport:SIDM00685,
ChEMBL-Cells:CHEMBL4295405,
ChEMBL-Targets:CHEMBL4296458,
CLS:305822,
Cosmic:849858,
Cosmic:1746957,
Cosmic:1995484,
Cosmic:2302322,
Cosmic:2367489,
Cosmic:2491101,
Cosmic-CLP:1240168,
DepMap:ACH-000819,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1240168,
GEO:GSM326196,
GEO:GSM397661,
GEO:GSM397662,
GEO:GSM887269,
GEO:GSM888344,
GEO:GSM1374620,
GEO:GSM1670048,
IARC_TP53:2570,
LiGeA:CCLE_635,
LINCS_LDP:LCL-1353,
Lonza:1681,
PharmacoDB:LN18_839_2019,
PRIDE:PXD000589,
PRIDE:PXD030304,
Progenetix:CVCL_0392,
PubChem_Cell_line:CVCL_0392,
Wikidata:Q54902768
CVCL_0392 2026-08-15 04:45:08 37
MOLT-3
 
Resource Report
Resource Website
1+ mentions
RRID:CVCL_0624 Homo sapiens (Human) Adult T acute lymphoblastic leukemia Karyotypic information: Hypertetraploid karyotype (ATCC=CRL-1552)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). PMID:327080
PMID:1086134
PMID:2846092
PMID:2985879
PMID:3159941
PMID:3518877
PMID:3856477
PMID:3874327
PMID:4547172
PMID:4567231
PMID:6220172
PMID:6600440
PMID:6978176
PMID:7630190
PMID:8547074
PMID:8608962
PMID:9738977
PMID:9787181
PMID:9933131
PMID:10739008
PMID:11986953
PMID:12623853
PMID:15472075
PMID:17170727
PMID:20215515
PMID:25877200
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:35354797
Cancer cell line Male Molt-3, MOLT 3, Molt 3, MOLT3, Molt3 BTO:BTO_0001081,
CLO:CLO_0007824,
CLO:CLO_0051008,
EFO:EFO_0005265,
CLDB:cl3519,
CLDB:cl3521,
CLDB:cl3522,
CLDB:cl3523,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-1552,
BCRC:60106,
BEI_Resources:ARP-12187,
BioSample:SAMN03470846,
BioSample:SAMN03471394,
BioSample:SAMN03472164,
BioSample:SAMN03473404,
BioSample:SAMN10989586,
cancercelllines:CVCL_0624,
Cell_Model_Passport:SIDM00153,
ChEMBL-Cells:CHEMBL3307556,
ChEMBL-Targets:CHEMBL614176,
CLS:300116,
Cosmic:724815,
Cosmic:850193,
Cosmic:913410,
Cosmic:999756,
Cosmic:1191701,
Cosmic:1281377,
Cosmic:1524845,
Cosmic:2301561,
Cosmic:2361367,
Cosmic:2602923,
DepMap:ACH-000964,
DSMZ:ACC-84,
DSMZCellDive:ACC-84,
ECACC:90021901,
GEO:GSM236793,
GEO:GSM236829,
GEO:GSM5137730,
IGRhCellID:MOLT3,
IZSLER:BS TCL 44,
JCRB:JCRB9048,
LiGeA:CCLE_717,
PharmacoDB:MOLT3_957_2019,
PRIDE:PXD023662,
Progenetix:CVCL_0624,
PubChem_Cell_line:CVCL_0624,
RCB:RCB1164,
Wikidata:Q54906351
CVCL_0624 2026-08-15 04:46:40 7
MOLT-4
 
Resource Report
Resource Website
100+ mentions
RRID:CVCL_0013 Homo sapiens (Human) Adult T acute lymphoblastic leukemia Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. PMID:165156
PMID:1765142
PMID:2041050
PMID:2140233
PMID:2144611
PMID:2846092
PMID:2985879
PMID:3159941
PMID:3335022
PMID:3874327
PMID:4547172
PMID:4567231
PMID:6181032
PMID:6198871
PMID:6200433
PMID:6582512
PMID:6954533
PMID:8127147
PMID:8316623
PMID:8547074
PMID:8558913
PMID:8641406
PMID:8957066
PMID:9331090
PMID:9510473
PMID:9685479
PMID:9787181
PMID:10071127
PMID:10700174
PMID:10739008
PMID:11021758
PMID:11226526
PMID:11416159
PMID:11986953
PMID:12068308
PMID:15472075
PMID:15748285
PMID:15901131
PMID:16408098
PMID:16957166
PMID:17088437
PMID:17117183
PMID:19372543
PMID:20164919
PMID:20215515
PMID:20922763
PMID:22068913
PMID:22347499
PMID:22384151
PMID:22460905
PMID:22628656
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24670534
PMID:24762992
PMID:25877200
PMID:26295583
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28196595
PMID:28569787
PMID:30894373
PMID:31068700
PMID:31160637
PMID:31733513
PMID:32449352
PMID:35354797
PMID:35839778
PMID:38861359
Cancer cell line Male Molt-4, MOLT 4, Molt 4, MOLT.4, MOLT4, Molt4, GM02219, GM02219C, GM2219C, GM02219D BTO:BTO_0000873,
CLO:CLO_0007825,
CLO:CLO_0032246,
CLO:CLO_0050992,
EFO:EFO_0001220,
MCCL:MCC:0000335,
CLDB:cl3524,
CLDB:cl3525,
CLDB:cl3527,
CLDB:cl3528,
CLDB:cl3529,
CLDB:cl3530,
CLDB:cl3531,
CLDB:cl3532,
CLDB:cl4976,
CLDB:cl5233,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
ATCC:CRL-1582,
BCRC:60060,
BCRJ:0176,
BioSample:SAMN03470847,
BioSample:SAMN03471400,
BioSample:SAMN03472410,
BioSample:SAMN03473319,
BioSample:SAMN10988202,
cancercelllines:CVCL_0013,
CCRID:1101HUM-PUMC000043,
CCRID:3101HUMTCHu224,
CCRID:4201HUM-CCTCC00083,
CCTCC:GDC0083,
Cell_Model_Passport:SIDM00145,
ChEMBL-Cells:CHEMBL3307557,
ChEMBL-Targets:CHEMBL614177,
CLS:300115,
Coriell:GM02219,
Cosmic:716176,
Cosmic:721716,
Cosmic:801730,
Cosmic:850194,
Cosmic:850381,
Cosmic:875865,
Cosmic:897451,
Cosmic:905958,
Cosmic:913409,
Cosmic:919154,
Cosmic:922677,
Cosmic:932766,
Cosmic:933547,
Cosmic:974249,
Cosmic:991545,
Cosmic:999763,
Cosmic:1012099,
Cosmic:1019314,
Cosmic:1044254,
Cosmic:1070704,
Cosmic:1071877,
Cosmic:1082518,
Cosmic:1092615,
Cosmic:1115596,
Cosmic:1118467,
Cosmic:1127263,
Cosmic:1130237,
Cosmic:1151788,
Cosmic:1175131,
Cosmic:1175857,
Cosmic:1176596,
Cosmic:1226858,
Cosmic:1305339,
Cosmic:1312325,
Cosmic:1330500,
Cosmic:1483362,
Cosmic:1509200,
Cosmic:1524808,
Cosmic:1639636,
Cosmic:1664513,
Cosmic:1811158,
Cosmic:1998457,
Cosmic:2039521,
Cosmic:2165720,
Cosmic:2361368,
Cosmic:2560251,
Cosmic:2602924,
Cosmic-CLP:905958,
dbMHC:48976,
DepMap:ACH-001127,
DSMZ:ACC-362,
DSMZCellDive:ACC-362,
ECACC:85011413,
ECACC:94022544,
EGA:EGAS00001000978,
GDSC:905958,
GEO:GSM2092,
GEO:GSM50196,
GEO:GSM50912,
GEO:GSM236794,
GEO:GSM236830,
GEO:GSM743460,
GEO:GSM750821,
GEO:GSM799348,
GEO:GSM799411,
GEO:GSM887336,
GEO:GSM888412,
GEO:GSM1178423,
GEO:GSM1178424,
GEO:GSM1178425,
GEO:GSM1181333,
GEO:GSM1181349,
GEO:GSM1670128,
GEO:GSM1696583,
GEO:GSM1696584,
GEO:GSM1696585,
GEO:GSM1696586,
GEO:GSM2124644,
GEO:GSM4471876,
GEO:GSM5137731,
GEO:GSM7701445,
GEO:GSM7701446,
IARC_TP53:27042,
ICLC:HTL99025,
IGRhCellID:MOLT4,
IHW:IHW09226,
IPD-IMGT/HLA:11094,
IZSLER:BS TCL 85,
JCRB:IFO50362,
JCRB:JCRB9031,
KCB:KCB 200940YJ,
KCLB:21582,
LINCS_LDP:LCL-1019,
Lonza:810,
NCBI_Iran:C149,
NCI-DTP:MOLT-4,
PharmacoDB:MOLT4_958_2019,
PRIDE:PXD003539,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD018565,
PRIDE:PXD023662,
PRIDE:PXD030304,
Progenetix:CVCL_0013,
PubChem_Cell_line:CVCL_0013,
RCB:RCB0206,
SKY/M-FISH/CGH:2741,
Ubigene:YC-C127,
Wikidata:Q54906365
CVCL_0013 2026-08-15 04:46:41 318
MOR
 
Resource Report
Resource Website
RRID:CVCL_2618 Homo sapiens (Human) Lung adenocarcinoma Population: Caucasian. PMID:3034934
PMID:7171457
PMID:7903701
PMID:25485619
PMID:25877200
PMID:26589293
Cancer cell line Sex unspecified MOR/P EFO:EFO_0006655,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03472982,
Cell_Model_Passport:SIDM01390,
ECACC:84112312,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
PharmacoDB:MOR_961_2019,
Wikidata:Q54906387
CVCL_2618 2026-08-15 04:46:42 0
MOR
 
Resource Report
Resource Website
ECACC Cat# 84112312, RRID:CVCL_2618 Homo sapiens (Human) Lung adenocarcinoma Population: Caucasian. PMID:3034934
PMID:7171457
PMID:7903701
PMID:25485619
PMID:25877200
PMID:26589293
Cancer cell line Sex unspecified MOR/P ECACC 84112312 EFO:EFO_0006655,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03472982,
Cell_Model_Passport:SIDM01390,
ECACC:84112312,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
PharmacoDB:MOR_961_2019,
Wikidata:Q54906387
CVCL_2618 2026-08-15 04:46:42 0
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
AddexBio Cat# T0016002/4922, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 AddexBio T0016002/4922 BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
JCRB Cat# IFO50073, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 JCRB IFO50073 BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
JCRB Cat# JCRB9008, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 JCRB JCRB9008 BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
CCTCC Cat# GDC0032, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 CCTCC GDC0032 BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
NCBI_Iran Cat# C125, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 NCBI_Iran C125 BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
KCB Cat# KCB 200412YJ, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 KCB KCB 200412YJ BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MRC-5
 
Resource Report
Resource Website
1000+ mentions
Discontinued
KCB Cat# KCB 89023YJ, RRID:CVCL_0440 Homo sapiens (Human) Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Senescence: Capable of attaining 42-46 population doublings before the onset of senescence (ATCC=CCL-171). Senesces at 26 PDL (PubMed=17395773)., Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax)., Biotechnology: Used for the production of the live varicella virus vaccine (Trade name: Varivax)., Biotechnology: Used for the production of the Hepatitis A vaccines Avaxim, Epaxal, Havrix and Vaqta., Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against rabies (Trade name: Imovax Rabies)., Group: Vaccine production cell line. PMID:113411
PMID:211143
PMID:932048
PMID:1031681
PMID:1193162
PMID:1756776
PMID:1965304
PMID:3335022
PMID:4316953
PMID:6538202
PMID:6971834
PMID:7065527
PMID:10752125
PMID:11416159
PMID:17395773
PMID:19657000
PMID:21637780
PMID:25877200
PMID:25903999
PMID:26477663
PMID:31869419
PMID:33389257
Finite cell line Male MRC5, MRC 5, MRCV, MRC-V, Medical Research Council cell strain-5 KCB KCB 89023YJ BTO:BTO_0001590,
CLO:CLO_0007865,
CLO:CLO_0050055,
EFO:EFO_0002835,
MCCL:MCC:0000336,
CLDB:cl3563,
CLDB:cl3564,
CLDB:cl3566,
CLDB:cl3567,
CLDB:cl3568,
CLDB:cl5168,
AddexBio:T0016002/4922,
ATCC:CCL-171,
BCRC:60023,
BCRJ:0180,
BioSample:SAMN01821580,
BioSample:SAMN01821702,
BioSample:SAMN01821735,
BioSample:SAMN03473183,
CCRID:1101HUM-PUMC000044,
CCRID:1102HUM-NIFDC00002,
CCRID:3101HUMGNHu41,
CCRID:3101HUMSCSP5040,
CCRID:4201HUM-CCTCC00032,
CCRID:5301HUM-KCB89023YJ,
CCTCC:GDC0032,
ChEMBL-Cells:CHEMBL3308499,
ChEMBL-Targets:CHEMBL614181,
CLS:300395,
ECACC:97112601,
FCS-free:179-2-338-1-16-3,
GEO:GSM248209,
GEO:GSM248210,
GEO:GSM520665,
GEO:GSM520666,
GEO:GSM520667,
GEO:GSM579888,
GEO:GSM579889,
GEO:GSM607969,
GEO:GSM3738752,
GEO:GSM3738753,
IBRC:C10313,
ICLC:HL95001,
IZSLER:BS CL 68,
JCRB:IFO50073,
JCRB:JCRB9008,
KCB:KCB 200412YJ,
KCB:KCB 89023YJ,
KCLB:10171,
Lonza:52,
NCBI_Iran:C125,
PRIDE:PXD001909,
PRIDE:PXD013120,
PRIDE:PXD023286,
PubChem_Cell_line:CVCL_0440,
RCB:RCB0211,
RCB:RCB0218,
Wikidata:Q3273166
CVCL_0440 2026-08-15 04:46:46 2876
MR6
 
Resource Report
Resource Website
RRID:CVCL_U183 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Population: African American. PMID:2372878
PMID:3608093
PMID:25877200
Cancer cell line Female CLO:CLO_0050916,
BioSample:SAMN03470988,
BioSample:SAMN03472275,
RCB:RCB0505,
Wikidata:Q54906577
cvcl_u209 CVCL_U183 2026-08-15 04:46:46 0
MR1-3
 
Resource Report
Resource Website
RCB Cat# RCB0504, RRID:CVCL_U180 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Population: African American. PMID:2372878
PMID:3608093
PMID:25877200
Cancer cell line Female RCB RCB0504 CLO:CLO_0050915,
BioSample:SAMN03470994,
Cosmic:753593,
RCB:RCB0504,
Wikidata:Q54906568
cvcl_u209 CVCL_U180 2026-08-15 04:46:46 0

Can't find your Cell Line?

We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.

If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.

Can't find the RRID you're searching for? X
X
  1. RRID Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.